abstract |
The present invention provides a compound, that is n nwherein Y, W, Z, R1, R2, R4, R5 and R6 are as defined in the specification.n n The compounds may be administered to treat DP, FP, EP1, TP and/or EP4 receptor-mediated diseases or conditions. |